AMBARELLA INC (AMBA)
KYG037AX1015 - Common Stock
Overall AMBA gets a fundamental rating of 4 out of 10. We evaluated AMBA against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for AMBA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, AMBA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
AMBA had negative earnings in the past year.
AMBA had a negative operating cash flow in the past year.
In the past 5 years AMBA always reported negative net income.
In the past 5 years AMBA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of AMBA (-26.85%) is worse than 85.19% of its industry peers.
The Return On Equity of AMBA (-30.87%) is worse than 78.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.85% | ||
| ROE | -30.87% | ||
| ROIC | N/A |
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 60.56%, AMBA belongs to the best of the industry, outperforming 84.26% of the companies in the same industry.
AMBA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 60.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-0.07%
2. Health
2.1 Basic Checks
AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMBA has more shares outstanding than it did 1 year ago.
AMBA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
AMBA has an Altman-Z score of 15.51. This indicates that AMBA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 15.51, AMBA belongs to the best of the industry, outperforming 87.96% of the companies in the same industry.
AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 15.51 |
ROIC/WACCN/A
WACC12.3%
2.3 Liquidity
AMBA has a Current Ratio of 3.69. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.69, AMBA is in the better half of the industry, outperforming 60.19% of the companies in the same industry.
AMBA has a Quick Ratio of 3.30. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
AMBA's Quick ratio of 3.30 is fine compared to the rest of the industry. AMBA outperforms 63.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.69 | ||
| Quick Ratio | 3.3 |
3. Growth
3.1 Past
The earnings per share for AMBA have decreased strongly by -635.29% in the last year.
The Revenue for AMBA has decreased by -24.15% in the past year. This is quite bad
The Revenue has been decreasing by -0.12% on average over the past years.
EPS 1Y (TTM)-635.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Sales Q2Q%2.58%
3.2 Future
Based on estimates for the next years, AMBA will show a very strong growth in Earnings Per Share. The EPS will grow by 42.70% on average per year.
The Revenue is expected to grow by 26.03% on average over the next years. This is a very strong growth
EPS Next Y4.67%
EPS Next 2Y31.62%
EPS Next 3Y53.4%
EPS Next 5Y42.71%
Revenue Next Year9.18%
Revenue Next 2Y17.04%
Revenue Next 3Y23.96%
Revenue Next 5Y26.03%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AMBA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AMBA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AMBA's earnings are expected to grow with 53.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.62%
EPS Next 3Y53.4%
5. Dividend
5.1 Amount
No dividends for AMBA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMBARELLA INC
NASDAQ:AMBA (9/6/2024, 8:00:00 PM)
After market: 51.99 -0.06 (-0.12%)52.05
-2.04 (-3.77%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.13B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.85% | ||
| ROE | -30.87% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 60.56% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.69 | ||
| Quick Ratio | 3.3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-635.29%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y4.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y0.52%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y